Track the PALVELLA THERAPEUTICS, INC. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.4bn. The latest transaction was filed on 20 August 2026 (Levée d'options). Among the most active insiders: Goin Kathleen. All data is openly available.
34
Insider Decl.
n/a
Thresholds
€816,630
5 ops.
Buy Volume
€2m
14 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate PALVELLA THERAPEUTICS, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
27Σ signal
Buys €816,630€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
2,154 shares@ US$7.142.6% of flowCommon StockSEC:0001104659-26-032695:0
25 of 34 declarations
Acerca de PALVELLA THERAPEUTICS, INC.
PALVELLA THERAPEUTICS, INC. es una empresa centrada en el desarrollo de tratamientos para enfermedades autoinmunes. Cotiza en NASDAQ bajo el ticker XNAS.